Companies › Amgen Inc.

Amgen Inc.

Company Pharma & Medical Devices

Amgen Inc. is listed as a company in Pharma & Medical Devices. It has filed 10 comment letters on 9 proposed federal rules between 2025 and 2026, most often with the Centers for Medicare & Medicaid Services.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
10
Rules commented on
9
First letter
2025-06-11
Latest letter
2026-09-08
Agencies most often
Centers for Medicare & Medicaid Services (8); Health and Human Services Department (1); Office of the Secretary (1)

Activity by year

20252
20268

Letters

2026

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-08

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-08

Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

CMS-2026-2344Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-01

Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program

CMS-2026-2245Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-08-25 · filed as “Amgen, Inc.”

Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard

CMS-2026-2081Health and Human Services Department · filed 2026-07-17 · filed as “Amgen, Inc.”

Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges

CMS-2026-1255Health and Human Services Department, Centers for Medicare & Medicaid Services, Office of the Secretary · filed 2026-06-29 · filed as “Amgen, Inc.”

Global Benchmark for Efficient Drug Pricing (GLOBE) Model

CMS-2025-1889Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25

Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

CMS-2025-1888Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25

2025

Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model

CMS-2025-0240Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-08-29

Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2026

CMS-2025-0031Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-06-11 · filed as “Amgen, Inc.”